Screening for Barrett's esophagus

Liam Zakko, Lori Lutzke, Kenneth Ke Ning Wang

Research output: Contribution to journalReview article

3 Citations (Scopus)

Abstract

Barrett's esophagus is the only known esophageal precursor for the development of esophageal adenocarcinoma. However, screening for Barrett's esophagus remains controversial. Although screening is advocated in selected populations, it is unclear how it should be implemented. In this review, the current definition of Barrett's esophagus will be discussed. There will be a review of the emerging evidence supporting the cost-effectiveness of screening and surveillance for Barrett's esophagus in preventing esophageal adenocarcinoma. The known risk factors for Barrett's esophagus and the development of esophageal adenocarcinoma, currently utilized to determine the appropriate populations to screen, will be reviewed. Finally we will review the standard techniques utilized to screen for Barrett's esophagus and examine new technologies that might improve the efficacy and availability of Barrett's esophagus screening.

Original languageEnglish (US)
Pages (from-to)28-42
Number of pages15
JournalMinerva Medica
Volume108
Issue number1
DOIs
StatePublished - Feb 1 2017

Fingerprint

Barrett Esophagus
Adenocarcinoma
Population
Cost-Benefit Analysis
Technology

Keywords

  • Adenocarcinoma of esophagus
  • Barrett esophagus
  • Mass screening

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Screening for Barrett's esophagus. / Zakko, Liam; Lutzke, Lori; Wang, Kenneth Ke Ning.

In: Minerva Medica, Vol. 108, No. 1, 01.02.2017, p. 28-42.

Research output: Contribution to journalReview article

Zakko, Liam ; Lutzke, Lori ; Wang, Kenneth Ke Ning. / Screening for Barrett's esophagus. In: Minerva Medica. 2017 ; Vol. 108, No. 1. pp. 28-42.
@article{18494b084b4449e7bd21415c319d478b,
title = "Screening for Barrett's esophagus",
abstract = "Barrett's esophagus is the only known esophageal precursor for the development of esophageal adenocarcinoma. However, screening for Barrett's esophagus remains controversial. Although screening is advocated in selected populations, it is unclear how it should be implemented. In this review, the current definition of Barrett's esophagus will be discussed. There will be a review of the emerging evidence supporting the cost-effectiveness of screening and surveillance for Barrett's esophagus in preventing esophageal adenocarcinoma. The known risk factors for Barrett's esophagus and the development of esophageal adenocarcinoma, currently utilized to determine the appropriate populations to screen, will be reviewed. Finally we will review the standard techniques utilized to screen for Barrett's esophagus and examine new technologies that might improve the efficacy and availability of Barrett's esophagus screening.",
keywords = "Adenocarcinoma of esophagus, Barrett esophagus, Mass screening",
author = "Liam Zakko and Lori Lutzke and Wang, {Kenneth Ke Ning}",
year = "2017",
month = "2",
day = "1",
doi = "10.23736/S0026-4806.16.04864-3",
language = "English (US)",
volume = "108",
pages = "28--42",
journal = "Minerva Medicolegale",
issn = "0026-4806",
publisher = "Edizioni Minerva Medica S.p.A.",
number = "1",

}

TY - JOUR

T1 - Screening for Barrett's esophagus

AU - Zakko, Liam

AU - Lutzke, Lori

AU - Wang, Kenneth Ke Ning

PY - 2017/2/1

Y1 - 2017/2/1

N2 - Barrett's esophagus is the only known esophageal precursor for the development of esophageal adenocarcinoma. However, screening for Barrett's esophagus remains controversial. Although screening is advocated in selected populations, it is unclear how it should be implemented. In this review, the current definition of Barrett's esophagus will be discussed. There will be a review of the emerging evidence supporting the cost-effectiveness of screening and surveillance for Barrett's esophagus in preventing esophageal adenocarcinoma. The known risk factors for Barrett's esophagus and the development of esophageal adenocarcinoma, currently utilized to determine the appropriate populations to screen, will be reviewed. Finally we will review the standard techniques utilized to screen for Barrett's esophagus and examine new technologies that might improve the efficacy and availability of Barrett's esophagus screening.

AB - Barrett's esophagus is the only known esophageal precursor for the development of esophageal adenocarcinoma. However, screening for Barrett's esophagus remains controversial. Although screening is advocated in selected populations, it is unclear how it should be implemented. In this review, the current definition of Barrett's esophagus will be discussed. There will be a review of the emerging evidence supporting the cost-effectiveness of screening and surveillance for Barrett's esophagus in preventing esophageal adenocarcinoma. The known risk factors for Barrett's esophagus and the development of esophageal adenocarcinoma, currently utilized to determine the appropriate populations to screen, will be reviewed. Finally we will review the standard techniques utilized to screen for Barrett's esophagus and examine new technologies that might improve the efficacy and availability of Barrett's esophagus screening.

KW - Adenocarcinoma of esophagus

KW - Barrett esophagus

KW - Mass screening

UR - http://www.scopus.com/inward/record.url?scp=85012856042&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85012856042&partnerID=8YFLogxK

U2 - 10.23736/S0026-4806.16.04864-3

DO - 10.23736/S0026-4806.16.04864-3

M3 - Review article

VL - 108

SP - 28

EP - 42

JO - Minerva Medicolegale

JF - Minerva Medicolegale

SN - 0026-4806

IS - 1

ER -